Phenotypic features associated with mutations in steroidogenic acute regulatory protein

被引:34
作者
Bhangoo, A
Gu, WX
Pavlakis, S
Anhalt, H
Heier, L
Ten, S
Jameson, JL
机构
[1] Infants & Childrens Hosp Brooklyn Maimonides, Pediat Endocrinol Div, Brooklyn, NY 11219 USA
[2] Infants & Childrens Hosp Brooklyn Maimonides, Div Pediat Neurol, Brooklyn, NY 11219 USA
[3] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metabol & Mol Med, Chicago, IL 60611 USA
[4] St Barnabas Hosp, Pediat Endocrinol Div, Livingston, NJ 07039 USA
[5] Cornell Univ, Weill Med Coll, Dept Radiol, New York, NY 10021 USA
关键词
D O I
10.1210/jc.2005-0434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Mutations in the gene encoding steroidogenic acute regulatory protein (StAR) are the most common cause of lipoid congenital adrenal hyperplasia (lipoid CAH), a disorder characterized by adrenal insufficiency and deficient gonadal steroid synthesis, resulting in female external genitalia in both genetic sexes. Objective: We describe three new cases of lipoid CAH caused by novel mutations in the StAR gene. Patients: An XY subject of Yemeni descent presented with adrenal insufficiency and severe undervirilization. Magnetic resonance imaging (MRI) of the brain showed enlarged subarachnoid spaces consistent with frontal and temporal atrophy. Two XX siblings of Palestinian descent presented with neonatal adrenal insufficiency. One had a borderline intelligence quotient and features of attention deficit hyperactivity disorder. MRI showed areas of supratentorial white matter lesions. In her sister, MRI revealed a Chiari-I malformation. Results: The XY subject was found to have a missense mutation (R182C). Both XX siblings had a dinucleotide deletion at nucleotides 327 - 328 that induces a frame shift that truncates the StAR protein after 68 amino acids. Conclusions: These cases broaden the spectrum of known StAR mutations and suggest that disorders of central nervous system development may arise because of StAR deficiency and/or the metabolic consequences of neonatal adrenal deficiency.
引用
收藏
页码:6303 / 6309
页数:7
相关论文
共 44 条
[1]   Molecular and structural analysis of two novel STAR mutations in patients with lipoid congenital adrenal hyperplasia [J].
Achermann, JC ;
Meeks, JJ ;
Jeffs, B ;
Das, U ;
Clayton, PE ;
Brook, CGD ;
Jameson, JL .
MOLECULAR GENETICS AND METABOLISM, 2001, 73 (04) :354-357
[2]   A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans [J].
Achermann, JC ;
Ito, M ;
Ito, M ;
Hindmarsh, PC ;
Jameson, JL .
NATURE GENETICS, 1999, 22 (02) :125-126
[3]   Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner [J].
Achermann, JC ;
Ozisik, G ;
Ito, M ;
Orun, UA ;
Harmanci, K ;
Gurakan, B ;
Jameson, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1829-1833
[4]   Spontaneous feminization in a 46,XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein [J].
Bose, HS ;
Pescovitz, OH ;
Miller, WL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) :1511-1515
[5]   The pathophysiology and genetics of congenital lipoid adrenal hyperplasia [J].
Bose, HS ;
Sugawara, T ;
Strauss, JF ;
Miller, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (25) :1870-1878
[6]   Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia [J].
Bose, HS ;
Sato, S ;
Aisenberg, J ;
Shalev, SA ;
Matsuo, N ;
Miller, WL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3636-3639
[7]   Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia [J].
Caron, KM ;
Soo, SC ;
Wetsel, WC ;
Stocco, DM ;
Clark, BJ ;
Parker, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11540-11545
[8]   A genetic isolate of congenital lipoid adrenal hyperplasia with atypical clinical findings [J].
Chen, X ;
Baker, BY ;
Abduljabbar, MA ;
Miller, WL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :835-840
[9]  
CLARK BJ, 1994, J BIOL CHEM, V269, P28314
[10]  
FISHER DA, 1998, ENDOCRINOLOGY TEST S, P297